Synconas investment proposition Long-term capital base Selective A productively deployed Focused portfolio and high evergreen funding base, convictioninvestment strategy, providing the ability to invest supported by deep scientific through the cycle, maximising andcommercial diligence.
Focus Strong partnership approach Innovative areas of healthcare A hands-on approach to with scientific potential for  to grow dramatic efficacy.
Specialists anddevelop into successful and in gene therapy, cell therapy sustainable standalone businesses.
Expertise Premium heritage and access Leading, multi-disciplinary High quality global networks, investment team with a and alignment with two premium proven track record ofcreating charitable funders inscience, valueforstakeholders.
the Wellcome Trust andCancer Research UK.
